Physiology and pathophysiology of the RANKL/RANK system

被引：40

作者：

Hanada, Reiko ^{[1
]}

Hanada, Toshikatsu ^{[1
]}

Penninger, Josef M. ^{[1
]}

机构：

[1] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria

来源：

BIOLOGICAL CHEMISTRY | 2010年 / 391卷 / 12期

基金：

欧洲研究理事会;

关键词：

bone physiology; central nervous systems; fever; immunology; osteoporosis; OSTEOCLAST DIFFERENTIATION FACTOR; BONE-MINERAL DENSITY; FACTOR RECEPTOR FAMILY; POSTMENOPAUSAL WOMEN; OSTEOPROTEGERIN-LIGAND; INHIBITS OSTEOCLASTOGENESIS; CRYSTAL-STRUCTURE; MAMMARY-GLAND; BREAST-CANCER; CELL FUNCTION;

D O I：

10.1515/BC.2010.149

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The TNF family molecule RANKL and its receptor RANK are key regulators of bone remodeling, lymph node formation, and mammary gland development during pregnancy. RANKL and RANK are also expressed in the central nervous systems (CNS). However, the functional relevance of RANKL/RANK in the brain was entirely unknown. Recently, our group reported that the RANKL/RANK signaling pathway has an essential role in the central regulation of body temperature via the prostaglandin axis. This review discusses novel aspects of the RANKL/RANK system as key regulators of fever and female basal body temperature in the CNS.

引用

页码：1365 / 1370

页数：6

共 53 条

[31] RANK/RANKL: Regulators of Immune Responses and Bone Physiology [J].

Leibbrandt, Andreas ;

Penninger, Josef M. .

YEAR IN IMMUNOLOGY 2008, 2008, 1143 :123-150

[32] RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism [J].

Li, J ;

Sarosi, I ;

Yan, XQ ;

Morony, S ;

Capparelli, C ;

Tan, HL ;

McCabe, S ;

Elliott, R ;

Scully, S ;

Van, G ;

Kaufman, S ;

Juan, SC ;

Sun, Y ;

Tarpley, J ;

Martin, L ;

Christensen, K ;

McCabe, J ;

Kostenuik, P ;

Hsu, H ;

Fletcher, F ;

Dunstan, CR ;

Lacey, DL ;

Boyle, WJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1566-1571

[33] Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone Metastases [J].

Lipton, Allan ;

Steger, Guenther G. ;

Figueroa, Jazmin ;

Alvarado, Cristina ;

Solal-Celigny, Philippe ;

Body, Jean-Jacques ;

de Boer, Richard ;

Berardi, Rossana ;

Gascon, Pere ;

Tonkin, Katia S. ;

Coleman, Robert ;

Paterson, Alexander H. G. ;

Peterson, Mark C. ;

Fan, Michelle ;

Kinsey, Amy ;

Jun, Susie .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4431-4437

[34] Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells [J].

Loser, Karin ;

Mehling, Annette ;

Loeser, Stefanie ;

Apelt, Jenny ;

Kuhn, Annegret ;

Grabbe, Stephan ;

Schwarz, Thomas ;

Penninger, Josef M. ;

Beissert, Stefan .

NATURE MEDICINE, 2006, 12 (12) :1372-1379

[35] Cytokines and fever - Mechanisms and sites of action [J].

Luheshi, GN .

MOLECULAR MECHANISMS OF FEVER, 1998, 856 :83-89

[36] Denosumab in postmenopausal women with low bone mineral density [J].

McClung, MR ;

Lewiecki, EM ;

Cohen, SB ;

Bolognese, MA ;

Woodson, GC ;

Moffett, AH ;

Peacock, M ;

Miller, PD ;

Lederman, SN ;

Chesnut, CH ;

Lain, D ;

Kivitz, AJ ;

Holloway, DL ;

Zhang, C ;

Peterson, MC ;

Bekker, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :821-831

[37] Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial [J].

Miller, Paul D. ;

Bolognese, Michael A. ;

Lewiecki, E. Michael ;

McClung, Michael R. ;

Ding, Beiying ;

Austin, Matthew ;

Liu, Yu ;

Martin, Javier San .

BONE, 2008, 43 (02) :222-229

[38] Central control of thermogenesis in mammals [J].

Morrison, Shaun F. ;

Nakamura, Kazuhiro ;

Madden, Christopher J. .

EXPERIMENTAL PHYSIOLOGY, 2008, 93 (07) :773-797

[39] Metastasis to bone: Causes, consequences and therapeutic opportunities [J].

Mundy, GR .

NATURE REVIEWS CANCER, 2002, 2 (08) :584-593

[40] RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis [J].

Nakagawa, N ;

Kinosaki, M ;

Yamaguchi, K ;

Shima, N ;

Yasuda, H ;

Yano, K ;

Morinaga, T ;

Higashio, K .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) :395-400

← 1 2 3 4 5 6 →